Literature DB >> 16244829

[Evidence-based evaluation of study results of symptomatic glucosamine therapy].

S Reiter1.   

Abstract

Meta-analyses can contribute to the field of evidence based medicine. In the systematic analyses so far published, the symptomatic efficacy of glucosamine was described to be moderate to large. The results of the individual clinical studies however do not support these findings unanimously. In the past couple of years, some new studies of high quality standard were published. This publication gives an overview and an evaluation of the current available studies for the symptomatic treatment of patients with gonarthrosis with glucosamine. It also compares the results of the individual studies with those of recent meta-analyses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244829     DOI: 10.1007/s00393-005-0777-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  22 in total

Review 1.  Glucosamine therapy for treating osteoarthritis.

Authors:  T E Towheed; T P Anastassiades; B Shea; J Houpt; V Welch; M C Hochberg
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  K M Jordan; N K Arden; M Doherty; B Bannwarth; J W J Bijlsma; P Dieppe; K Gunther; H Hauselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; B Leeb; M Lequesne; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; U Serni; B Swoboda; G Verbruggen; I Zimmerman-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

3.  The algofunctional indices for hip and knee osteoarthritis.

Authors:  M G Lequesne
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

4.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

5.  Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop.

Authors:  R Altman; K Brandt; M Hochberg; R Moskowitz; N Bellamy; D A Bloch; J Buckwalter; M Dougados; G Ehrlich; M Lequesne; S Lohmander; W A Murphy; T Rosario-Jansen; B Schwartz; S Trippel
Journal:  Osteoarthritis Cartilage       Date:  1996-12       Impact factor: 6.576

6.  Glucosamine sulfate in osteoarthritis of the knee.

Authors:  W Noack; M Fischer; K K Förster; L C Rovati; I Setnikar
Journal:  Osteoarthritis Cartilage       Date:  1994-03       Impact factor: 6.576

7.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

8.  Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.

Authors:  J P Rindone; D Hiller; E Collacott; N Nordhaugen; G Arriola
Journal:  West J Med       Date:  2000-02

9.  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee.

Authors:  R Hughes; A Carr
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

10.  Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis.

Authors:  J M Pujalte; E P Llavore; F R Ylescupidez
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.